I was just a the lovenox site for reference. There is NO mention as to clinical trials or to dosing with IV.
http://www.lovenox.com/consumer/thrombosis/heparin1.do
I'm not refuting, or arguing with the posters stating that IV is used, simply stating that the drugs own site does not provide safe IV dosing or provide a recommended IV dose with clinical proof of the risks vrs. bennies.
Our facility is strictly sq, with reopro, integrillin and all the what not's... can anyone give me some clinical info as to WHY this would be preferred.... aside from quicker onset of action... but why not just the glycoproteins, heparin or thrombolysis... with the manufacturer not stating an IV use?
Is there new literature out ther? PLEASE share it, so we can improve our outcomes!
thanks all